Development of an Age- and Comorbidity- Adjusted Optimal Radiotherapy Utilisation Rate for Lung, Rectal, Prostate and Cervical Cancers.

[1]  P. Malani,et al.  Experiences of Everyday Ageism and the Health of Older US Adults , 2022, JAMA network open.

[2]  T. Comans,et al.  Development of an age- and comorbidity adjusted- optimal radiotherapy utilisation rate for women with breast cancer. , 2022, Journal of geriatric oncology.

[3]  S. Vinod,et al.  Single-Fraction vs Multifraction Stereotactic Ablative Body Radiotherapy for Pulmonary Oligometastases (SAFRON II): The Trans Tasman Radiation Oncology Group 13.01 Phase 2 Randomized Clinical Trial. , 2021, JAMA oncology.

[4]  F. Voncken,et al.  Contemporary radiotherapy: present and future , 2021, The Lancet.

[5]  H. Wildiers,et al.  Priorities for the global advancement of care for older adults with cancer: an update of the International Society of Geriatric Oncology Priorities Initiative. , 2021, The Lancet. Oncology.

[6]  T. Comans,et al.  Factors affecting radiotherapy utilisation in geriatric oncology patients in NSW, Australia , 2020, Technical innovations & patient support in radiation oncology.

[7]  S. Vinod,et al.  Radiotherapy underutilisation and its impact on local control and survival in New South Wales, Australia. , 2019, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[8]  M. Aapro,et al.  Updated recommendations of the International Society of Geriatric Oncology on prostate cancer management in older patients. , 2019, European journal of cancer.

[9]  Tomas Kron,et al.  Stereotactic ablative radiotherapy versus standard radiotherapy in stage 1 non-small-cell lung cancer (TROG 09.02 CHISEL): a phase 3, open-label, randomised controlled trial. , 2019, The Lancet. Oncology.

[10]  A. Street,et al.  Development and validation of a Hospital Frailty Risk Score focusing on older people in acute care settings using electronic hospital records: an observational study , 2018, The Lancet.

[11]  K. Ballman,et al.  National trends in management of localized prostate cancer: A population based analysis 2004‐2013 , 2018, The Prostate.

[12]  H. Wildiers,et al.  What Every Oncologist Should Know About Geriatric Assessment for Older Patients With Cancer: Young International Society of Geriatric Oncology Position Paper. , 2018, Journal of oncology practice.

[13]  S. Vinod,et al.  The population benefit of evidence-based radiotherapy: 5-Year local control and overall survival benefits. , 2017, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[14]  J. Borrás,et al.  Demand for radiotherapy in Spain , 2017, Clinical and Translational Oncology.

[15]  T. Hsu.  Educational initiatives in geriatric oncology - Who, why, and how? , 2016, Journal of geriatric oncology.

[16]  B. Møller,et al.  Lung cancer treatment is influenced by income, education, age and place of residence in a country with universal health coverage , 2016, International journal of cancer.

[17]  Peter Dunscombe,et al.  The optimal utilization proportion of external beam radiotherapy in European countries: An ESTRO-HERO analysis. , 2015, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[18]  H. Wildiers,et al.  Screening tools for multidimensional health problems warranting a geriatric assessment in older cancer patients: an update on SIOG recommendations†. , 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

[19]  G. Jerusalem,et al.  Ageism and its clinical impact in oncogeriatry: state of knowledge and therapeutic leads , 2014, Clinical interventions in aging.

[20]  S. Mathoulin-Pélissier,et al.  Screening for Vulnerability in Older Cancer Patients: The ONCODAGE Prospective Multicenter Cohort Study , 2014, PloS one.

[21]  H. Wildiers,et al.  International Society of Geriatric Oncology consensus on geriatric assessment in older patients with cancer. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  Timothy P Hanna,et al.  Estimating the demand for radiotherapy from the evidence: a review of changes from 2003 to 2012. , 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[23]  N. Pearce,et al.  Cancer-specific administrative data-based comorbidity indices provided valid alternative to Charlson and National Cancer Institute Indices. , 2014, Journal of clinical epidemiology.

[24]  M. Aapro,et al.  Ageism in cancer care , 2014, BMJ : British Medical Journal.

[25]  S. Mathoulin-Pélissier,et al.  Screening older cancer patients: first evaluation of the G-8 geriatric screening tool. , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

[26]  S. Mohile,et al.  Research priorities in geriatric oncology: addressing the needs of an aging population. , 2012, Journal of the National Comprehensive Cancer Network : JNCCN.

[27]  Jose Belderbos,et al.  Impact of introducing stereotactic lung radiotherapy for elderly patients with stage I non-small-cell lung cancer: a population-based time-trend analysis. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  G. Stevens,et al.  Radiotherapy utilisation in lung cancer in New Zealand: disparities with optimal rates explained. , 2009, The New Zealand medical journal.

[29]  M. Barton,et al.  An evidence-based estimation of local control and survival benefit of radiotherapy for breast cancer. , 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[30]  Geoff Delaney,et al.  The role of radiotherapy in cancer treatment , 2005, Cancer.

[31]  H. Cohen,et al.  Use of comprehensive geriatric assessment in older cancer patients: recommendations from the task force on CGA of the International Society of Geriatric Oncology (SIOG). , 2005, Critical reviews in oncology/hematology.

[32]  M. Barton,et al.  Estimating the optimal external‐beam radiotherapy utilization rate for genitourinary malignancies , 2005, Cancer.

[33]  M. Barton,et al.  Estimation of an optimal radiotherapy utilization rate for gastrointestinal carcinoma , 2004, Cancer.

[34]  M. Barton,et al.  Estimation of an optimal radiotherapy utilization rate for gynecologic carcinoma , 2004, Cancer.

[35]  M. Barton,et al.  Estimation of an optimal radiotherapy utilization rate for breast carcinoma , 2003, Cancer.

[36]  B. Jalaludin,et al.  A model for decision making for the use of radiotherapy in lung cancer. , 2003, The Lancet. Oncology.

[37]  Damon Jones,et al.  Implementation of geriatric education into the first and second years of a baccalaureate-MD degree program. , 2002, Academic medicine : journal of the Association of American Medical Colleges.

[38]  L. Sobin,et al.  Prognostic factors in clinical decision making , 2001, Cancer.

[39]  S. Engelholm,et al.  Radiotherapy in the management of cervical cancer in elderly patients. , 2000, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[40]  S. Tyldesley,et al.  Association between age and the utilization of radiotherapy in Ontario. , 2000, International journal of radiation oncology, biology, physics.

[41]  K. Fushimi,et al.  American Journal of Epidemiology Practice of Epidemiology Updating and Validating the Charlson Comorbidity Index and Score for Risk Adjustment in Hospital Discharge Abstracts Using Data from 6 Countries , 2022 .